Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229694864> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W4229694864 endingPage "S126" @default.
- W4229694864 startingPage "S125" @default.
- W4229694864 abstract "The optimal cutoff for systolic blood pressure (SBP) level to define high-risk pulmonary embolism (PE) remains to be defined.To evaluate the relationship between SBP levels on admission and mortality in patients with acute symptomatic PE, the current study included 39,257 consecutive patients with acute symptomatic PE from the RIETE registry between 2001 and 2018. Primary outcomes included all-cause and PE-specific 30-day mortality. Secondary outcomes included major bleeding and recurrent venous thromboembolism (VTE).There was a linear inverse relationship between admission SBP and 30-day all-cause and PE-related mortality that persisted after multivariable adjustment. Patients in the lower SBP strata had higher rates of all-cause death (reference: SBP 110–129 mmHg) (adjusted odds ratio [OR] 2.9; 95% confidence interval [CI], 2.0–4.2 for SBP <70 mmHg; and OR 1.7; 95% CI, 1.4–2.1 for SBP 70–89 mmHg). The findings for 30-day PE-related mortality were similar (adjusted OR 4.4; 95% CI, 2.7–7.2 for SBP <70 mmHg; and OR 2.6; 95% CI, 1.9–3.4 for SBP 70–89 mmHg). Patients in the higher strata of SBP had significantly lower rates of 30-day all-cause mortality compared with the same reference group (adjusted OR 0.7; 95% CI, 0.5–0.9 for SBP 170–190 mmHg; and OR 0.6; 95% CI, 0.4–0.9 for SBP >190 mmHg). Consistent findings were also observed for 30-day PE-related death.In patients with acute symptomatic PE, a low SBP portends an increased risk of all-cause and PE-related mortality. The highest mortality was observed in patients with SBP <70 mmHg." @default.
- W4229694864 created "2022-05-11" @default.
- W4229694864 creator A5000561694 @default.
- W4229694864 creator A5017896316 @default.
- W4229694864 creator A5037457447 @default.
- W4229694864 creator A5039411128 @default.
- W4229694864 creator A5046102296 @default.
- W4229694864 creator A5066762999 @default.
- W4229694864 creator A5068925617 @default.
- W4229694864 creator A5075307725 @default.
- W4229694864 creator A5087556097 @default.
- W4229694864 date "2019-12-01" @default.
- W4229694864 modified "2023-10-14" @default.
- W4229694864 title "P.161 Factors affecting the efficacy of adjunctive aripiprazole in risperidone- or paliperidone-induced hyperprolactinemia" @default.
- W4229694864 doi "https://doi.org/10.1016/j.euroneuro.2019.09.208" @default.
- W4229694864 hasPublicationYear "2019" @default.
- W4229694864 type Work @default.
- W4229694864 citedByCount "0" @default.
- W4229694864 crossrefType "journal-article" @default.
- W4229694864 hasAuthorship W4229694864A5000561694 @default.
- W4229694864 hasAuthorship W4229694864A5017896316 @default.
- W4229694864 hasAuthorship W4229694864A5037457447 @default.
- W4229694864 hasAuthorship W4229694864A5039411128 @default.
- W4229694864 hasAuthorship W4229694864A5046102296 @default.
- W4229694864 hasAuthorship W4229694864A5066762999 @default.
- W4229694864 hasAuthorship W4229694864A5068925617 @default.
- W4229694864 hasAuthorship W4229694864A5075307725 @default.
- W4229694864 hasAuthorship W4229694864A5087556097 @default.
- W4229694864 hasConcept C118552586 @default.
- W4229694864 hasConcept C126322002 @default.
- W4229694864 hasConcept C156957248 @default.
- W4229694864 hasConcept C164705383 @default.
- W4229694864 hasConcept C207103383 @default.
- W4229694864 hasConcept C2776265017 @default.
- W4229694864 hasConcept C2776412080 @default.
- W4229694864 hasConcept C2777126507 @default.
- W4229694864 hasConcept C2780057945 @default.
- W4229694864 hasConcept C44249647 @default.
- W4229694864 hasConcept C71924100 @default.
- W4229694864 hasConcept C84393581 @default.
- W4229694864 hasConcept C90924648 @default.
- W4229694864 hasConceptScore W4229694864C118552586 @default.
- W4229694864 hasConceptScore W4229694864C126322002 @default.
- W4229694864 hasConceptScore W4229694864C156957248 @default.
- W4229694864 hasConceptScore W4229694864C164705383 @default.
- W4229694864 hasConceptScore W4229694864C207103383 @default.
- W4229694864 hasConceptScore W4229694864C2776265017 @default.
- W4229694864 hasConceptScore W4229694864C2776412080 @default.
- W4229694864 hasConceptScore W4229694864C2777126507 @default.
- W4229694864 hasConceptScore W4229694864C2780057945 @default.
- W4229694864 hasConceptScore W4229694864C44249647 @default.
- W4229694864 hasConceptScore W4229694864C71924100 @default.
- W4229694864 hasConceptScore W4229694864C84393581 @default.
- W4229694864 hasConceptScore W4229694864C90924648 @default.
- W4229694864 hasLocation W42296948641 @default.
- W4229694864 hasOpenAccess W4229694864 @default.
- W4229694864 hasPrimaryLocation W42296948641 @default.
- W4229694864 hasRelatedWork W2018814163 @default.
- W4229694864 hasRelatedWork W2022392719 @default.
- W4229694864 hasRelatedWork W2064447907 @default.
- W4229694864 hasRelatedWork W2097100909 @default.
- W4229694864 hasRelatedWork W2417485714 @default.
- W4229694864 hasRelatedWork W2793590385 @default.
- W4229694864 hasRelatedWork W2804529914 @default.
- W4229694864 hasRelatedWork W3038392370 @default.
- W4229694864 hasRelatedWork W3154231528 @default.
- W4229694864 hasRelatedWork W3162666314 @default.
- W4229694864 hasVolume "29" @default.
- W4229694864 isParatext "false" @default.
- W4229694864 isRetracted "false" @default.
- W4229694864 workType "article" @default.